I wonder how they will go with recruitment if they are upfront about the disease model they are addressing with the CBT.
Here's the recruitment page:
Moe na COVID-19? | Doe mee aan de ReCOVer studie
They outright state:
"We already know that chronic fatigue can succesfully be treated with cognitive behaviour therapy."
To continue: "We wonder if cognitive behaviour therapy can also help prevent that fatigue after COVID-19 becomes chronic."
("We weten al dat chronische vermoeidheid succesvol kan worden behandeld met cognitieve gedragstherapie. We vragen ons af of cognitieve gedragstherapie ook kan helpen voorkomen dat vermoeidheid na COVID-19 chronisch wordt.")
In the opening part of the text it is emphasised twice that the study will be about seeing if CBT
prevents chronic fatigue.
It also says that participants from the control group who are still fatigued after the trial will still* be offered "Fit after COVID".
*It doesn't translate well, but the word "alsnog" in Dutch implies that they have missed out the first time, like something is corrected which should have happened in the first round.
(Deelnemers uit de controlegroep die na afronding van het onderzoek nog steeds moe zijn, krijgen alsnog “Fit na COVID” aangeboden.)
This doesn't only influence the control group in how they would subjectively assess their condition in the trial (because it is set against a we-know-this-works treatment the other group is getting, which they know will be offered to them too after they are done), but it also prevents long term follow up comparison between the groups.
I don't know if it's usual, but the study aim is also emphasised (again) explicitly: "The hope is that patients are less tired after "Fit after COVID" and the fatigue complaints do not get chronic"
(De hoop is dat patiënten minder moe zijn na “Fit na COVID” en de vermoeidheidsklachten niet chronisch worden.) So both treatment arms will have this expectation of the treatment when they apply.
Also application was for patients who were fatigued between 3-12 months, a lot of time to recover naturally anyway (as lots of Long COVID patients have thankfully been doing in the first 18 months). This fact alone will give no doubt about this trial being called "succesful", because it's a sure thing that there will be improvement in treatment arm patients.
And then there's the prominent logo's and mention of five participating hospitals. Combined with the rest it seems used to instill a sense of authority/effectiveness.
I think the trial has already started and I guess they didn't explain this way?
They at least didn't at the recruitment page. The trial was full on 27-8-2021, and they started recruiting at least since February, so I'm guessing they are well on their way.
edited: small bit of clarifying text added